Thanks to our proprietary advanced technologies and algorithms, Trilogy with AVAPS-AE decreases CO2 and improves treatment effectiveness and quality of life for patients. This is why Trilogy is the most widely dispensed home ventilator in North America.1 Trilogy with AVAPS-AE has multiple algorithms designed to work simultaneously addressing the needs of your complex patients.
Trilogy100 Portable Ventilator Trilogy with Bluetooth technology enables connected care to help improve efficiencies, enables costs while giving clinicians the information they need to improve patient outcomes.
Light, versatile, easy-to-use, Bluetooth enabled, and with proven technology. Trilogy100 makes invasive and noninvasive treatment less complicated for a wide range of adult and pediatric patients.
Back in the Game
Doug Veazey is a former high school, All American football player. 40 years ago he was struck by a disease that paralyzed his diaphragm. He almost gave up hope. But Trilogy ventilators helped him change his life, and now he can breathe comfortably.
1 Philips–sponsored market survey study of 120 DMEs on the brands of ventilators the DMEs set-up for patients in May 2016. 2 TechValidate survey funded by Philips Respironics of 114 users of: Philips Respironics Trilogy Ventilator with AVAPS-AE, n=114 https://www.techvalidate.com/tvid/18C-FE2-164 3 TechValidate survey funded by Philips Respironics of 114 users of: Philips Respironics Trilogy Ventilator with AVAPS-AE, n=114 https://www.techvalidate.com/tvid/705-29C-437
You are about to visit a Philips global content page
Continue